by Mobile health vehicles provide medical screening, preventive care services, and general healthcare needs to communities lacking adequate access to medical facilities. Equipped with basic medical diagnostic tools and point-of-care testing equipment along with a team of healthcare professionals, these ambulances travel to remote and rural regions on a pre-determined schedule to conduct health checkups and screenings. The services offered include basic tests like blood pressure monitoring, blood sugar level checks, general physical examination, vaccination, and health counselling. Considering lack of medical infrastructure in underdeveloped areas, these mobile clinics play a crucial role in identifying health issues at an early stage and preventing the onset of chronic diseases.
The Global Mobile Health Vehicle Market Size is estimated to be valued at US$ 281.9 Mn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the primary drivers for the rising adoption of mobile health vehicles is growing focus on preventive healthcare globally. With non-communicable diseases accounting for over 70% of all deaths annually worldwide, governments and health organizations are promoting preventive measures to curb the increasing disease burden. Mobile healthcare delivery helps in mass screening of at-risk populations and timely interventions to curb avoidable health issues. Moreover, technological advancements are enabling these ambulances to be equipped with advanced diagnostic tools which were earlier available only at tertiary care hospitals. This is improving the accessibility and quality of healthcare in remote regions.
Porter’s Analysis
Threat of new entrants: Low barriers to entry such as low initial cost and regulations allows new players to enter the market easily.
Bargaining power of buyers: Large number of buyers and mobile health vehicles results in high bargaining power of buyers.They can negotiate on prices and demand customized features.
Bargaining power of suppliers: Low differentiation between components used in mobile health vehicles gives suppliers high bargaining power over manufacturers.
Threat of new substitutes: Alternative healthcare options pose threat of substitution to some non-critical services offered through mobile health vehicles.
Competitive rivalry: Intense competition exists among existing players to gain higher market share through product differentiation, new features and competitive pricing.
Key Takeaways
The global Mobile Health Vehicle market is expected to witness high growth. The global Mobile Health Vehicle Market is estimated to be valued at US$ 281.9 Mn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024 to 2031.
Regional analysis comprises– North America dominates the market currently due to presence of major players and high adoption of mobile health vehicles. Asia Pacific is expected to grow at fastest pace owing to increasing healthcare infrastructure especially in rural areas of countries like India and China.
Key players operating in the Mobile Health Vehicle market are Ecolab Inc., Novozymes A/S, Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., The Clorox Company, Kikkoman Corporation, Spartan Chemical Company, Inc., Diversey, Inc., Johnson & Johnson, Danaher Corporation, Henkel AG & Co. KGaA, Procter & Gamble Co., DuPont de Nemours, Inc., Colgate-Palmolive Company, and Biokleen. Ecolab Inc. and Novozymes A/S collectively account for over 30% market share currently.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
